SK bioscience Co.,Ltd. (KRX: 302440)
South Korea flag South Korea · Delayed Price · Currency is KRW
44,850
+150 (0.34%)
Nov 18, 2024, 3:30 PM KST

SK bioscience Co.,Ltd. Revenue

SK bioscience Co.,Ltd. had revenue of 26.78B KRW in the quarter ending June 30, 2024, with 1.13% growth. This brings the company's revenue in the last twelve months to 371.48B, up 33.42% year-over-year. In the year 2023, SK bioscience Co.,Ltd. had annual revenue of 369.51B, down -19.10%.

Revenue (ttm)
371.48B
Revenue Growth
+33.42%
P/S Ratio
9.27
Revenue / Employee
377.52M
Employees
984
Market Cap
3,513.88B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023369.51B-87.22B-19.10%
Dec 31, 2022456.73B-472.28B-50.84%
Dec 31, 2021929.00B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition